Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia

References

• Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010; 16:217-225; PMID:20375783
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. FDA expands use of Prevnar 13 vaccine for people ages 50 and older. 2011. Available from URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm285431.htm. [Accessed January 27, 2016]
   Google Scholar
• The Committee for Medicinal Products for Human Use. European Medicines Agency. Prevenar-13. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed). United Kingdom 2011. Available from URL: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/001104/WC500112838.pdf. [Accessed February 16, 2016]
   Google Scholar
• The Office of Disease Prevention and Health Promotion. Healthy people 2020. Immunization and Infectious Diseases Available from URL: https://www.healthypeople.gov/2020/data-search/Search-the-Data?nid=4706 [Accessed January 22, 2016]
   Google Scholar
• Vila-Corcoles A, Ochoa-Gondar O, Ester F, Sarrá N, Ansa X, Saún N; EVAN Study Group. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health 2006; 6:231; PMID:16981982; http://dx.doi.org/10.1186/1471-2458-6-231
   PubMed Web of Science ®Google Scholar
• Picazo JJ, González-Romo F, García Rojas A, Peréz-Trallero E, Gil Gregorio P, de la Cámara R, Morató ML, Rodríguez A, Barberán J, Domínguez Hernández V, et al. Consensus document on pneumococcal vaccination in adults with risk underlying clinical conditions. [In spanish] Rev Esp Quimioter 2013; 26:232-252
   PubMed Web of Science ®Google Scholar
• O'Halloran AC, Lu PJ, Pilishvili T. Pneumococcal vaccination coverage among persons ≥65 years-United States, 2013. Vaccine 2015; 33:5503-6; PMID:26372859; http://dx.doi.org/10.1016/j.vaccine.2015.09.002
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O'Halloran A, Bridges CB, Kim DK, Pilishvili T, Hales CM, Markowitz LE, Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). Vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64:95-102; PMID:25654611
   PubMed Web of Science ®Google Scholar
• Grabenstein JD, Weber DJ. Pneumococcal Serotype Diversity Among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake. Clin Infect Dis 2014; 58:854-64; PMID:24344141; http://dx.doi.org/10.1093/cid/cit800
   PubMed Web of Science ®Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015; 372:1114-25; PMID:25785969; http://dx.doi.org/10.1056/NEJMoa1408544
   PubMed Web of Science ®Google Scholar
• Swartz AW. Vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 373:91-2; PMID:26132953; http://dx.doi.org/10.1056/NEJMc1505366
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Bruhn CA, Shapiro ED. Vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 373:92; PMID:26132955
   PubMed Web of Science ®Google Scholar
• Musher DM, Rodriguez-Barradas MB. Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant. Hum Vaccin Immunother 2016; 12:331-5; PMID:26606172; http://dx.doi.org/10.1080/21645515.2015.1098794
   PubMed Web of Science ®Google Scholar
• Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, Salleras L, Samson SI. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Rev Vaccines 2011; 10:1143-67; PMID:21810065; http://dx.doi.org/10.1586/erv.11.99
   PubMed Web of Science ®Google Scholar
• Spindler C, Hedlund J, Jasir A, Normark BH, Ortqvist A. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine 2008; 26:5541-46; PMID:18602961; http://dx.doi.org/10.1016/j.vaccine.2008.06.073
   PubMed Web of Science ®Google Scholar
• Gavazzi G, Wazieres B, Lejeune B, Rothan-Tondeur M. Influenza and pneumococcal vaccine coverages in geriatric health care settings in France. Gerontology 2007; 53:382-7; PMID:17622768; http://dx.doi.org/10.1159/000105166
   PubMed Web of Science ®Google Scholar
• Delelis-Fanien AS, Seite F, Priner M, Paccalin M. Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients. Rev Med Interne 2009; 30:656-60; PMID:19345448; http://dx.doi.org/10.1016/j.revmed.2008.12.026
   PubMed Web of Science ®Google Scholar
• Martinelli D, Tafuri S, Caputi G, Fortunato F, Reggio P, Germinario C, Prato R. Eight years of active proposal of pneumococcal 23valent polysaccharide vaccine: survey on coverage rate among elderly and chronic patients. Am J Infect Control 2010; 38:e8-e15; PMID:20211508; http://dx.doi.org/10.1016/j.ajic.2009.09.019
   PubMedGoogle Scholar
• Begum F, Pebody R. Annual pneumococcal polysaccharide vaccine uptake in 65 years old and over for England. Influenza immunization uptake monitoring programme. Department of Health and Health Protection Agency 2008. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1216711845635
   Google Scholar
• Bossuyt N, Van Casteren V. Pneumococcal vaccination coverage in elderly people in Belgium. Arch Public Health 2005; 63:185-98
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP). Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR 2010; 59(34):1102-6; PMID:20814406
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816-9; PMID:23051612
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2014; 63:822-5; PMID:25233284
   PubMed Web of Science ®Google Scholar
• World Health Organization. Weekly epidemiological record. Pneumococcal vaccines. WHO position paper – 2012. Available from URL: http://www.who.int/wer/2012/wer8714.pdf?ua=1 [Accessed February 8, 2016]
   Google Scholar
• British Thoracic Society. Community acquired pneumonia in adults guideline. Available from URL: https://www.brit-thoracic.org.uk/guidelines-and-quality-standards/community-acquired-pneumonia-in-adults-guideline/[Accessed February 8, 2016]
   Google Scholar
• European Centre for Disease Prevention and Control. Vaccine Schedule. Recommended immunisations for pneumococcal disease. Available from URL: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx [Accessed March 8, 2016]
   Google Scholar
• Castiglia P. Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe. Adv Ther 2014; 31:1011-44; PMID:25300593; http://dx.doi.org/10.1007/s12325-014-0157-1
   PubMed Web of Science ®Google Scholar
• García-Gil M del M, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, Rodriguez J, Williams T, Van Staa T, Bolibar B: Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care 2011; 19:135-145; PMID:Can't
   PubMedGoogle Scholar
• González R, Armadans L, Martínez X, Moraga F, Campins M. Pneumococcal vaccination coverage in at-risk children in Catalonia. [in Spanish]. Enferm Infecc Microbiol Clin 2015; 33:597-602; PMID:Can't; http://dx.doi.org/10.1016/j.eimc.2015.01.003
   PubMedGoogle Scholar
• Information system for the development of research in primary care (SIDIAP data base). Available from URL: [http://www.sidiap.org/]
   Google Scholar
• Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46(RR-8):1-24; PMID:9011775
   PubMedGoogle Scholar